scholarly journals Impact of abdominal composition CT-profile on postoperative complications after curative resection for pancreatic cancer

HPB ◽  
2019 ◽  
Vol 21 ◽  
pp. S699-S700
Author(s):  
O. Belyaev ◽  
M. Fraziano ◽  
T. Herzog ◽  
W. Uhl
2020 ◽  
Vol 6 (2) ◽  
Author(s):  
ümit Mercan ◽  
Ogün Erşen ◽  
Ali Ekrem Ünal

Objective: This study aimed to investigate the effect of sarcopenia on the development of serious postoperative complications in patients who underwent curative pancreatectomy for pancreatic cancer. Methods: Total psoas index (TPI) was calculated for sarcopenia diagnosis by measures of psoas muscle area on the level of L3 spine from preoperative staging computerised tomograhpy (CT) images in pancreatic cancer patients undergoing curative resection. Patient demographics and postoperative outcomes were analised  in sarcopenic and non-sarcopenic group. Results: It has been found to be statistically significant relation between severe postoperative complication and sarcopenia (p=0,001>). Sarcopenia was more associated with cardiac and pulmoner complications among others (p=0.007, p=0.003 respectively). In multivariate analysis, age (OR: 1,08. %95 CI: 1,01~1,15, p=0,013), ASA score (OR: 2,84. 95% CI 1,62 ~ 4,97. p= 0,043) and TPI (OR: 3,61. 95% CI: 1,58 ~ 5,74. p= 0,001>) has been found independent risk factors for severe postoperative complications.   Conclusion: Our results suggest that sarcopenia determined by using TPI, which can be easily obtained by examining the preoperative CT imaging, is an independent risk factor of severe postoperative complications. Determining the degree of sarcopenia can affect patient selection, predictability of possible serious complications, elective operation preparation process with a combination of nutrition and exercise therapy in a particular patient group and decisions regarding adjuvant or neoadjuvant therapy.


HPB ◽  
2021 ◽  
Vol 23 ◽  
pp. S917
Author(s):  
I. Mora Oliver ◽  
D. Dorcaratto ◽  
M.L. Molina ◽  
L. Pérez ◽  
E. Muñoz ◽  
...  

Surgery Today ◽  
1999 ◽  
Vol 29 (1) ◽  
pp. 16-22 ◽  
Author(s):  
Hideo Ozaki ◽  
Takehisa Hiraoka ◽  
Ryuji Mizumoto ◽  
Seiki Matsuno ◽  
Yoshiro Matsumoto ◽  
...  

Pancreatology ◽  
2019 ◽  
Vol 19 (5) ◽  
pp. 686-694 ◽  
Author(s):  
Naoya Kasahara ◽  
Hiroshi Noda ◽  
Nao Kakizawa ◽  
Takaharu Kato ◽  
Fumiaki Watanabe ◽  
...  

2018 ◽  
Vol 52 ◽  
pp. 303-308 ◽  
Author(s):  
Javier A. Cienfuegos ◽  
Jorge Baixauli ◽  
Carmen Beorlegui ◽  
Patricia Martínez Ortega ◽  
Lucía Granero ◽  
...  

2008 ◽  
Vol 74 (7) ◽  
pp. 602-606 ◽  
Author(s):  
Stephen H. Gray ◽  
Mary T. Hawn ◽  
Meredith L. Kilgore ◽  
Huifeng Yun ◽  
John D. Christein

Early diagnosis and curative resection are significant predictors of survival in patients with pancreatic cancer. We hypothesize that cholecystectomy within 12 months of pancreatic cancer affects 1-year survival. The Surveillance Epidemiology and End Result (SEER) database linked to Medicare data was used to identify patients diagnosed with pancreatic cancer who underwent cholecystectomy 1 to 12 months prior to cancer diagnosis. The SEER database identified 32,569 patients from 1995 to 2002; 415 (1.3%) underwent cholecystectomy prior to cancer diagnosis. Patients who underwent cholecystectomy had a higher proportion of diabetes (40.2% vs 20.5%; P < 0.01), obesity (8.9% vs 3.1%; P < 0.01), jaundice (17.3% vs 0.7%; P < 0.01), cholelithiasis (70.4% vs 4.2%; P < 0.01), choledocholithiasis (0.7% vs 0.0%; P < 0.01), weight loss (17.3% vs 4.7%; P < 0.01), abdominal pain (79.5% vs 22.5%), steatorrhea (0.7% vs 0.0%; P < 0.01), and cholecystitis (32.3% vs 1.7%; P < 0.0001). After controlling for tumor stage, patient demographics, and symptoms, survival at 1 year was significantly lower in patients undergoing cholecystectomy (OR, 0.75; 95% CI, 0.58–0.97). Recent cholecystectomy is associated with decreased 1-year survival among patients with pancreatic cancer. For patients older than 65 years of age, further evaluation prior to cholecystectomy may be necessary to exclude pancreatic cancer, especially patients with jaundice, weight loss, and steatorrhea.


Sign in / Sign up

Export Citation Format

Share Document